FR2600253B1 - Nouvelles compositions pharmaceutiques a base de ketotifene - Google Patents

Nouvelles compositions pharmaceutiques a base de ketotifene

Info

Publication number
FR2600253B1
FR2600253B1 FR878708505A FR8708505A FR2600253B1 FR 2600253 B1 FR2600253 B1 FR 2600253B1 FR 878708505 A FR878708505 A FR 878708505A FR 8708505 A FR8708505 A FR 8708505A FR 2600253 B1 FR2600253 B1 FR 2600253B1
Authority
FR
France
Prior art keywords
ketotifene
pharmaceutical compositions
compositions based
new pharmaceutical
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR878708505A
Other languages
English (en)
Other versions
FR2600253A1 (fr
Inventor
Hansruedi Surer
Aldo Riva
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2600253A1 publication Critical patent/FR2600253A1/fr
Application granted granted Critical
Publication of FR2600253B1 publication Critical patent/FR2600253B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR878708505A 1986-06-21 1987-06-18 Nouvelles compositions pharmaceutiques a base de ketotifene Expired - Lifetime FR2600253B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3620830 1986-06-21

Publications (2)

Publication Number Publication Date
FR2600253A1 FR2600253A1 (fr) 1987-12-24
FR2600253B1 true FR2600253B1 (fr) 1990-01-26

Family

ID=6303418

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878708505A Expired - Lifetime FR2600253B1 (fr) 1986-06-21 1987-06-18 Nouvelles compositions pharmaceutiques a base de ketotifene

Country Status (30)

Country Link
US (1) US5399360A (fr)
JP (2) JPS638332A (fr)
KR (1) KR880000095A (fr)
AT (1) AT400521B (fr)
AU (1) AU611637B2 (fr)
BE (1) BE1000661A4 (fr)
CA (1) CA1314227C (fr)
CH (3) CH672735A5 (fr)
CY (1) CY1589A (fr)
DE (1) DE3719818C2 (fr)
DK (1) DK314387A (fr)
ES (1) ES2006170A6 (fr)
FI (1) FI872733A (fr)
FR (1) FR2600253B1 (fr)
GB (1) GB2191696B (fr)
GR (1) GR870965B (fr)
HK (1) HK27691A (fr)
HU (1) HU202753B (fr)
IE (1) IE59178B1 (fr)
IL (1) IL82924A (fr)
IT (1) IT1216822B (fr)
LU (1) LU86928A1 (fr)
MY (1) MY101566A (fr)
NL (1) NL8701335A (fr)
NO (1) NO872551L (fr)
NZ (1) NZ220769A (fr)
PH (1) PH26313A (fr)
PT (1) PT85128B (fr)
SE (1) SE8702563L (fr)
ZA (1) ZA874450B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
EP1014979A4 (fr) 1997-06-09 2003-08-20 Bridge Pharma Inc Composes a combinaison d'activites antihistaminique et stabilisatrice des membranes cellulaires de mastocytes, utilises a des fins ophtalmiques
US6740889B1 (en) * 1998-09-28 2004-05-25 Applied Materials, Inc. Charged particle beam microscope with minicolumn
WO2001039774A1 (fr) * 1999-12-01 2001-06-07 Klein Pharmaceuticals Administration topique de ketotifene
US20030153620A1 (en) * 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ514536A (en) * 2001-09-28 2005-02-25 Meracol Corp Ltd Use of cetyl myristate and/or cetyl palmitate to treat asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
ITMI20012366A1 (it) * 2001-11-09 2003-05-09 Farmatron Ltd Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
JP4867128B2 (ja) * 2002-10-01 2012-02-01 大正製薬株式会社 経口鼻炎治療用組成物
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US8481565B2 (en) * 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
WO2008153761A1 (fr) * 2007-05-23 2008-12-18 Mastcell Pharmaceuticals, Inc. Méthodes
WO2009142772A2 (fr) 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Méthodes et traitement d’allergies et inflammations associées à des pathologies gastro-intestinales
EP2441445A1 (fr) * 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Revêtement de particules de cetyl myristate et/ou cetyl palmitate

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH531000A (de) * 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
DE2426811A1 (de) * 1974-06-04 1976-01-08 Klinge Co Chem Pharm Fab Verfahren zur herstellung von retard-tabletten
US4073915A (en) * 1975-05-20 1978-02-14 Sandoz Ltd. Treating asthma
JPS51142543A (en) * 1975-05-20 1976-12-08 Sandoz Ag Improvement in organic compound
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
HU197847B (en) * 1984-03-01 1989-06-28 Sandoz Ag Process for producing therapeutical preparations suitable for transdermatic treating
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
IT1200102B (it) * 1984-08-16 1989-01-05 Sandoz Ag Preparazioni farmaceutiche comprendenti chetotifere ed una xartina ad azione antiasmatica in combinazione fissa
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule

Also Published As

Publication number Publication date
IL82924A0 (en) 1987-12-20
AT400521B (de) 1996-01-25
CH674805A5 (fr) 1990-07-31
MY101566A (en) 1991-12-17
NO872551D0 (no) 1987-06-18
NZ220769A (en) 1990-12-21
IE871634L (en) 1987-12-21
GB2191696A (en) 1987-12-23
JPH05246849A (ja) 1993-09-24
DE3719818C2 (de) 1997-02-13
LU86928A1 (fr) 1988-01-20
FR2600253A1 (fr) 1987-12-24
CH672735A5 (fr) 1989-12-29
JP2860013B2 (ja) 1999-02-24
PT85128A (en) 1987-07-01
PT85128B (pt) 1990-03-30
HU202753B (en) 1991-04-29
GB8714131D0 (en) 1987-07-22
PH26313A (en) 1992-04-23
AU7452587A (en) 1987-12-24
IE59178B1 (en) 1994-01-26
NO872551L (no) 1987-12-22
JPS638332A (ja) 1988-01-14
AU611637B2 (en) 1991-06-20
HUT47428A (en) 1989-03-28
CA1314227C (fr) 1993-03-09
GR870965B (en) 1987-10-20
ES2006170A6 (es) 1989-04-16
KR880000095A (ko) 1988-03-23
NL8701335A (nl) 1988-01-18
ATA156187A (de) 1995-06-15
BE1000661A4 (fr) 1989-03-07
CY1589A (en) 1992-04-03
SE8702563L (sv) 1987-12-22
DK314387A (da) 1987-12-22
IT8748075A0 (it) 1987-06-19
GB2191696B (en) 1991-01-16
DK314387D0 (da) 1987-06-19
HK27691A (en) 1991-04-19
US5399360A (en) 1995-03-21
IL82924A (en) 1992-11-15
SE8702563D0 (sv) 1987-06-18
ZA874450B (en) 1989-01-25
DE3719818A1 (de) 1987-12-23
CH676201A5 (fr) 1990-12-28
FI872733A0 (fi) 1987-06-18
IT1216822B (it) 1990-03-14
FI872733A (fi) 1987-12-22

Similar Documents

Publication Publication Date Title
FR2636238B1 (fr) Nouvelles compositions antisudorales
SE8801813L (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
FR2636532B1 (fr) Compositions pharmaceutiques
FR2600253B1 (fr) Nouvelles compositions pharmaceutiques a base de ketotifene
IT8920486A0 (it) Composizioni farmaceutiche.
FR2600893B1 (fr) Nouvelles compositions pharmaceutiques a base de sels de calcium
FI872313A0 (fi) Farmaceutiska kompositioner.
FI883673A0 (fi) Farmaceutiska kompositioner.
FR2624012B1 (fr) Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
MC1878A1 (fr) Compositions pharmaceutiques
DE3877063D1 (de) Photopolymerisierbare dentalzusammensetzung.
FR2665835B1 (fr) Nouvelles compositions pharmaceutiques a base de clozapine.
FR2661830B1 (fr) Nouvelle compositions pharmaceutiques a base de flavonoside.
BE879786A (fr) Nouvelles compositions pharmaceutiques a base d'aryltrifluoro-ethanol
BE863723A (fr) Nouvelles compositions pharmaceutiques a base de chlorhexidine
BE890311A (fr) Nouvelles compositions pharmaceutiques a base d'un derive de la 1,4-dihydropyridine
DE3866419D1 (de) Photopolymerisierbare dentalzusammensetzung.
IT1213320B (it) Composizione farmaceutica orale a base di ubichinoni.
MX11584A (es) Composiciones farmaceuticas
IT1216814B (it) Composizioni farmaceutiche
FR2572933B1 (fr) Compositions pharmaceutiques topiques a base de tizanidine
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
FR2604091B1 (fr) Nouvelles compositions pharmaceutiques a base d'un derive de la benzodiazepine
FR2521008B1 (fr) Nouvelles compositions pharmaceutiques a base de thioridazine

Legal Events

Date Code Title Description
TP Transmission of property